Ozcan Karaman Selected Research

Ozcan Karaman Research Topics

2	Weight Loss (Weight Reduction) 03/2022 - 11/2007
2	Acromegaly 01/2018 - 01/2015
2	Neoplasms (Cancer) 05/2017 - 10/2015
2	Arteriovenous Fistula 01/2008 - 03/2007
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 03/2022
1	Morbid Obesity 03/2022
1	Prolactinoma (Prolactinomas) 10/2015
1	Craniopharyngioma (Craniopharyngiomas) 12/2011
1	Glioma (Gliomas) 12/2011
1	Inflammation (Inflammations) 01/2009
1	Anemia 01/2008
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2008
1	Fistula 01/2008
1	Hypertension (High Blood Pressure) 01/2008
1	Pulmonary Hypertension 01/2008
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2008
1	Vascular Diseases (Vascular Disease) 01/2008
1	Non-alcoholic Fatty Liver Disease 11/2007
1	Insulin Resistance 11/2007
1	Hemorrhage 05/2007
1	Necrosis 05/2007
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2007
1	Restless Legs Syndrome (Restless Legs) 01/2007

2	ProlactinIBA 05/2017 - 10/2015
1	Anti-Mullerian HormoneIBA 03/2022
1	AntioxidantsIBA 01/2018
1	Superoxide DismutaseIBA 01/2018
1	Cabergoline FDA LinkGeneric 10/2015
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 10/2015
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2015
1	hydroxide ionIBA 01/2015
1	Temozolomide (Temodar)FDA LinkGeneric 12/2011
1	Malondialdehyde (Propanedial)IBA 01/2009
1	Hemoglobins (Hemoglobin)IBA 01/2008
1	CalciumIBA 01/2008
1	Parathyroid Hormone (Parathormone)IBA 01/2008
1	Phosphorus (Red Phosphorus)IBA 01/2008
1	EnzymesIBA 11/2007
1	Transaminases (Aminotransferases)IBA 11/2007
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2007

4	Renal Dialysis (Hemodialysis) 01/2008 - 01/2007
1	Bariatric Surgery 03/2022
1	Aftercare (After-Treatment) 10/2015
1	Adjuvant Radiotherapy 12/2011
1	Therapeutics 12/2011